Phenotype
|
Fish
|
Conditions
|
Figures
|
brain il1b expression increased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 6
from Zhang et al., 2024
|
brain bcl2a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
brain bbc3 expression increased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
brain gad1b expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
developmental growth delayed, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV2
from Zhang et al., 2024
|
brain elavl3 expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
swimming behavior process quality, ameliorated
|
nomozf3952/zf3952
|
chemical treatment by environment: minocycline
|
Figure 6
from Zhang et al., 2024
|
social behavior decreased process quality, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 4 ,
Figure 6 ,
Figure 7
from Zhang et al., 2024
|
brain serotonin increased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 7
from Zhang et al., 2024
|
brain L-dopa increased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 7
from Zhang et al., 2024
|
locomotory behavior decreased process quality, abnormal
|
nomozf3952/zf3952
|
altered light dark cycle
|
Figure 2
from Zhang et al., 2024
|
social behavior decreased process quality, exacerbated
|
nomozf3952/zf3952
|
chemical treatment by environment: 4-chloro-L-phenylalanine
|
Fig. EV4
from Zhang et al., 2024
|
midbrain neurog1 expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3
from Zhang et al., 2024
|
brain inflammatory response increased frequency, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 6
from Zhang et al., 2024
|
yolk malformed, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV2
from Zhang et al., 2024
|
brain melatonin increased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 7
from Zhang et al., 2024
|
neuron decreased ratio forebrain, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 1
from Zhang et al., 2024
|
brain egr2b expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
locomotory behavior decreased process quality, abnormal
|
nomozf3952/zf3952
|
chemical treatment by environment: minocycline
|
Figure 6
from Zhang et al., 2024
|
neuroectoderm foxb1a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3
from Zhang et al., 2024
|
brain sim1a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
brain il6 expression increased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 6
from Zhang et al., 2024
|
social behavior decreased process quality, abnormal
|
nomozf3952/zf3952
|
chemical treatment by environment: melatonin
|
Figure 7
from Zhang et al., 2024
|
head nomo expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 1
from Zhang et al., 2024
|
pericardium edematous, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV2
from Zhang et al., 2024
|
neuron decreased ratio telencephalon, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 1
from Zhang et al., 2024
|
brain pidd1 expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
hindbrain foxb1a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3
from Zhang et al., 2024
|
brain th expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3
from Zhang et al., 2024
|
locomotory behavior increased rate, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 6
from Zhang et al., 2024
|
locomotory behavior increased rate, abnormal
|
nomozf3952/zf3952
|
chemical treatment by environment: minocycline
|
Figure 6
from Zhang et al., 2024
|
brain neurog1 expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
whole organism nomo expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 1
from Zhang et al., 2024
|
locomotory behavior process quality, ameliorated
|
nomozf3952/zf3952
|
chemical treatment by environment: 4-chloro-L-phenylalanine
|
Fig. EV4
from Zhang et al., 2024
|
hindbrain isl1a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3
from Zhang et al., 2024
|
social behavior decreased process quality, abnormal
|
nomozf3952/zf3952
|
chemical treatment by environment: minocycline
|
Figure 6
from Zhang et al., 2024
|
brain fezf2 expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
brain decreased mass, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 1
from Zhang et al., 2024
|
brain dlx2a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
brain il6 expression increased amount, abnormal
|
nomozf3952/zf3952
|
chemical treatment by environment: minocycline
|
Figure 6
from Zhang et al., 2024
|
brain isl1a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
hindbrain neurog1 expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3
from Zhang et al., 2024
|
locomotory behavior process quality, ameliorated
|
nomozf3952/zf3952
|
chemical treatment by environment: melatonin
|
Figure 7
from Zhang et al., 2024
|
habenula neuron decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 1
from Zhang et al., 2024
|
larval locomotory behavior increased rate, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 3
from Zhang et al., 2024
|
midbrain foxb1a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3
from Zhang et al., 2024
|
midbrain isl1a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3
from Zhang et al., 2024
|
epiphysis neuron decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 1
from Zhang et al., 2024
|
locomotory behavior decreased process quality, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 3 ,
Figure 6 ,
Figure 7
from Zhang et al., 2024
|
brain bcl2l1 expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
brain il1b expression amount, ameliorated
|
nomozf3952/zf3952
|
chemical treatment by environment: minocycline
|
Figure 6
from Zhang et al., 2024
|
caudal fin bent, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV2
from Zhang et al., 2024
|
brain apoptotic process increased frequency, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 6
from Zhang et al., 2024
|
swimming behavior decreased process quality, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 6
from Zhang et al., 2024
|
brain foxb1a expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Fig. EV3,
Figure 5
from Zhang et al., 2024
|
brain nomo expression decreased amount, abnormal
|
nomozf3952/zf3952
|
standard conditions
|
Figure 1
from Zhang et al., 2024
|
neuronal stem cell RFP expression decreased amount, abnormal
|
nomozf3952/zf3952; fdu101Tg/fdu101Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
hindbrain GABAergic neuron EGFP expression decreased amount, abnormal
|
nomozf3952/zf3952; ion84Tg/ion84Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
spinal cord GABAergic neuron EGFP expression decreased amount, abnormal
|
nomozf3952/zf3952; ion84Tg/ion84Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
forebrain GABAergic neuron EGFP expression decreased amount, abnormal
|
nomozf3952/zf3952; ion84Tg/ion84Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
midbrain GABAergic neuron EGFP expression decreased amount, abnormal
|
nomozf3952/zf3952; ion84Tg/ion84Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
midbrain glutamatergic neuron DsRed expression decreased amount, abnormal
|
nomozf3952/zf3952; nns14Tg/nns14Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
forebrain glutamatergic neuron DsRed expression decreased amount, abnormal
|
nomozf3952/zf3952; nns14Tg/nns14Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
spinal cord glutamatergic neuron DsRed expression decreased amount, abnormal
|
nomozf3952/zf3952; nns14Tg/nns14Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|
hindbrain glutamatergic neuron DsRed expression decreased amount, abnormal
|
nomozf3952/zf3952; nns14Tg/nns14Tg
|
standard conditions
|
Figure 5
from Zhang et al., 2024
|